Security Snapshot

Edesa Biotech, Inc. - Common Shares, without par value (EDSA) Institutional Ownership

CUSIP: 27966L306

13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

21

Shares (Excl. Options)

3,052,670

Price

$1.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Shares, without par value
Symbol
EDSA on Nasdaq
Shares outstanding
8,406,552
Price per share
$5.90
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,052,670
Total reported value
$4,339,133
% of total 13F portfolios
0%
Share change
+175,962
Value change
+$168,466
Number of holders
21
Price from insider filings
$5.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • EDSA - Edesa Biotech, Inc. - Common Shares, without par value is tracked under CUSIP 27966L306.
  • 21 institutions reported positions in Q4 2025.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 21 to 7 between Q4 2025 and Q1 2026.
  • Reported value moved from $4,339,133 to $865,166.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 21 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 27966L306?
CUSIP 27966L306 identifies EDSA - Edesa Biotech, Inc. - Common Shares, without par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nijhawan Pardeep 20% 0% $2,510,166 +$546,371 2,040,785 +28% Pardeep Nijhawan 26 Feb 2026
Nantahala Capital Management, LLC 10% 0% $1,266,263 +$229,541 855,583 +22% Nantahala Capital Management, LLC 31 Dec 2025
Velan Capital Investment Management LP 10% 0% $1,026,681 +$173,613 834,700 +20% Velan Capital Investment Management LP 26 Feb 2026
Stonepine Capital Management, LLC 9.9% $1,636,780 693,551 Stonepine Capital Management, LLC 13 Feb 2025
Point72 Asset Management, L.P. 7.2% $588,000 600,000 Point72 Asset Management, L.P. 24 Feb 2026
PERCEPTIVE ADVISORS LLC 6.7% $551,974 563,239 Perceptive Advisors LLC 09 Mar 2026

As of 31 Dec 2025, 21 institutional investors reported holding 3,052,670 shares of Edesa Biotech, Inc. - Common Shares, without par value (EDSA). This represents 36% of the company’s total 8,406,552 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Rubric Capital Management LP 8.2% 687,500 0% 0.01% $976,250
Velan Capital Investment Management LP 8.2% 687,500 0% 0.57% $976,250
Stonepine Capital Management, LLC 8.2% 687,500 0% 0.78% $976,250
Nantahala Capital Management, LLC 7.4% 625,000 0% 0.05% $887,500
DRW Securities, LLC 1.6% 134,222 0.01% $190,595
DIADEMA PARTNERS LP 0.64% 54,025 0.05% $76,716
CITADEL ADVISORS LLC 0.64% 53,630 +282% 0% $77,764
GEODE CAPITAL MANAGEMENT, LLC 0.55% 46,537 +2.9% 0% $67,484
VANGUARD GROUP INC 0.45% 37,600 -17% 0% $54,520
STATE STREET CORP 0.22% 18,679 0% $27,085
Persistent Asset Partners Ltd 0.15% 12,319 0.01% $17,493
Tower Research Capital LLC (TRC) 0.03% 2,554 +100% 0% $3,627
MORGAN STANLEY 0.03% 2,300 0% $3,266
ROYAL BANK OF CANADA 0.02% 1,659 -8.6% 0% $2,000
UBS Group AG 0.02% 1,362 -25% 0% $1,934
TD Waterhouse Canada Inc. 0% 142 0% 0% $200
Global Retirement Partners, LLC 0% 86 +244% 0% $122
BANK OF AMERICA CORP /DE/ 0% 52 +2% 0% $74
Dogwood Wealth Management LLC 0% 1 0% 0% $1
DANSKE BANK A/S 0% 1 0% 0% $1
LRI Investments, LLC 0% 1 0% 0% $1
CITIGROUP INC 0% 0 -100% $0
RENAISSANCE TECHNOLOGIES LLC 0% 0 -100% $0
COMMONWEALTH EQUITY SERVICES, LLC 0% 0 -100% $0
FIFTH THIRD BANCORP 0% 0 -100% $0

Institutional Holders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 165,423 $865,166 +$206,516 $5.23 7
2025 Q4 3,052,670 $4,339,133 +$168,466 $1.42 21
2025 Q3 2,876,709 $7,101,619 +$1,897,089 $2.47 23
2025 Q2 2,108,117 $4,279,068 -$1,739,763 $2.03 20
2025 Q1 2,822,207 $6,885,740 +$6,475,156 $2.44 19
2024 Q4 207,513 $350,110 +$46,292 $1.68 16
2024 Q3 161,348 $718,217 +$49,169 $4.45 17
2024 Q2 150,715 $645,126 +$183,339 $4.28 17
2024 Q1 107,880 $450,876 -$12,949 $4.19 17
2023 Q4 110,845 $507,117 +$507,117 $4.57 19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .